News

IO Biotech was named to Fast Company’s World’s Most Innovative Companies of 2025 list for its potentially game-changing approach to immune-modulatory cancer vaccines, earning its place on the coveted ...
Initiation of AERIAL trial accelerated by successful first close of Series A1 financing  LEU011 is first CAR-T candidate for the treatment of solid tumours to be manufactured ...
Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotech company developing RNA interference (RNAi) ...
May 06, 2025 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a late-stage clinical biotechnology company focused on developing therapies to counteract the devastating progression of ...
Currently, several such platforms are in various stages of development ... these platforms is restricted by the current state-of-the-art in CCD array technology. Simply put, these cameras have ...
We may draw upon all information from your previous applications or any previous registrations at the University as a student when assessing your suitability for your chosen course. Our MSc ...
Hi! I'm Baileigh, a Digital Content Producer with 25 News KXXV and 15 ABC KRHD. COLLEGE STATION, Texas (KRHD) — Texas A&M AgriLife Research and the Texas A&M University System celebrated the ...
Drawing from its long history ... more flexible platform for news reporting, coming online in stages from 2022. This is allowing The Pharma Letter to provide more evergreen content, with data-driven ...
The Biotechnology Program has also expanded its STEM outreach efforts to include a summer internship program for high school ...
At stake in the ongoing patent dispute over the gene-editing tool are rights to the most important new biotechnology of the ...
In rats, which had a more aggressive form of the disease with faster progression, the disease was slowed down. In these experiments, eye pressure was left untreated, which the researchers ...
A Classics researcher at the University of Cincinnati is using today's technology to learn more about the mass production and ...